CIK 0001374328 · Non-accelerated filer<br>Smaller reporting company
FITLIFE BRANDS, INC.
Sign in to watch- Ticker
- FTLF
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- Phone
- 402-884-1894
- Business address
- 5214 S. 136TH STREET, OMAHA, NE, 68137
- Former names
- BOND LABORATORIES, INC.
- 4 Grant or award Director acquired 266 shares (grant or award)
- 4 Conversion CHIEF EXECUTIVE OFFICER acquired 123,222 shares (conversion)
- 4 Grant or award Director acquired 375 shares (grant or award)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 1,000 shares at $8.73 ($8,730)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 40,508 shares at $9.75 ($394,953)
- 4/A Grant or award Director acquired 406 shares (grant or award)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 52,000 shares at $8.50 ($442,000)
- 4 Grant or award Director acquired 406 shares (grant or award)
- 4 Grant or award Director acquired 6,697 shares (grant or award)
- 4 Grant or award Director acquired 13,393 shares (grant or award)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 12,000 shares at $0.50 ($6,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 224,455 shares at $0.50 ($112,228)
- 4 Grant or award Director acquired 8,721 shares (grant or award)
- 4 Grant or award Director acquired 13,082 shares (grant or award)
- 4 Grant or award Director acquired 13,082 shares (grant or award)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 1,110,999 shares at an average $0.49 ($546,317)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 49,400 shares at an average $0.35 ($17,327)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 27,169 shares at an average $0.40 ($10,894)
Page 3 of 9 · 175 filings